Top

International Journal of Clinical Oncology

Published in:

01-06-2014 | Review Article

Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma

Author: Ken Omura

Published in: International Journal of Clinical Oncology | Issue 3/2014

Abstract

The primary treatment modality of oral cancer is generally determined according to the stage of the disease, with surgical treatment remaining the mainstay of multimodal treatment. When selecting the treatment, many factors are taken into consideration, and the treatment should be tailored individually to the patient’s needs and consider the quality of life as well as the survival of the patient. Early-stage disease is primarily managed with surgery or brachytherapy without functional morbidity, whereas for advanced-stage disease multidisciplinary treatment is recommended, not only for enhanced survival but also for improved quality of life. After resection of large primary tumors, reconstructive surgery is required. Free tissue transfer currently represents one of the most popular and reliable techniques for oral reconstruction. For cN0 neck, elective neck dissection is recommended when the risk of occult metastases is >20 %, when the neck is entered either for resection of the primary tumor or for reconstruction, or when the patient is unlikely to return for a close follow-up. Sentinel node biopsy is performed investigationally. Modified radical neck dissection is the gold standard for cN+ neck. For patients with multiple node metastases or extracapsular spread, postoperative radiotherapy or chemoradiotherapy is recommended, with the lymph nodes situated outside the confines of the radical neck dissection, such as the lingual and retropharyngeal nodes, receiving considerable attention. Targeted therapy for oral cancer is still a relatively new concept, and more studies are needed to confirm the clinical effectiveness of these drugs.

Ariyoshi Y, Shimahara M, Omura K et al (2008) Epidemiological study of malignant tumors in the oral and maxillofacial region: survey of member institutions of the Japanese Society of Oral and Maxillofacial Surgeons, 2002. Int J Clin Oncol 13:220–228PubMedCrossRef

McGuirt WF (1982) Panendoscopy as a screening examination for simultaneous primary tumors in head and neck cancer: a prospective sequential study and review of the literature. Laryngoscope 92:569–576PubMedCrossRef

Saikawa M, Ebihara S, Yoshizumi T et al (1991) Multiple primary cancers in patients with squamous cell carcinoma of the oral cavity. Jpn J Cancer Res 82:40–45PubMedCrossRef

Sutton DN, Brown JS, Rogers SN et al (2003) The prognostic implications of the surgical margin in the oral squamous cell carcinoma. Int J Oral Maxillofac Surg 32:30–34PubMedCrossRef

McMahon J, O’Brien CJ, Pathak I et al (2003) Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. Br J Oral Maxillofac Surg 41:224–231PubMedCrossRef

Mistry RC, Qureshi SS, Kumaran C (2005) Post-resection mucosal margin shrinkage in oral cancer: quantification and significance. J Surg Oncol 91:131–133PubMedCrossRef

Meier JD, Oliver DA, Varvares MA (2005) Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey. Head Neck 27:952–958PubMedCrossRef

Kurita H, Kurashina K (1996) Vital staining with iodine solution in delineating the border of oral dysplastic lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81:275–280PubMedCrossRef

Xiao T, Kurita H, Shimane T et al (2013) Vital staining with iodine solution in oral cancer: iodine infiltration, cell proliferation, and glucose transporter 1. Int J Clin Oncol 18:792–800PubMedCrossRef

10.

Petruzzi M, Lucchese A, Baldoni E et al (2010) Use of Lugol’s iodine in oral cancer diagnosis: an overview. Oral Oncol 46:811–813PubMedCrossRef

11.

Hidalgo DA, Disa JD, Cordeiro PG et al (1998) A review of 716 consecutive free flaps for oncologic surgical defects: refinements in donor site selection and technique. Plast Reconstr Surg 102:722–732PubMed

12.

Sakuraba M, Miyamoto S, Kimata Y et al (2013) Recent advances in reconstructive surgery: head and neck reconstruction. Int J Clin Oncol 18:561–565PubMedCrossRef

13.

Kudoh M (2010) Longitudinal assessment of articulatory and masticatory functions following glossectomy for tongue carcinoma. Kokubyo Gakkai Zasshi 77:27–34PubMed

14.

Lam L, Samman N (2013) Speech and swallowing following tongue cancer surgery and free flap reconstruction—a systematic review. Oral Oncol 49:507–524PubMedCrossRef

15.

Kimata Y, Sakuraba M, Hishinuma S et al (2003) Analysis of the relations between the shape of the reconstructed tongue and postoperative functions after subtotal or total glossectomy. Laryngoscope 113:905–909PubMedCrossRef

16.

Yanai C, Kikutani T, Adachi M et al (2008) Functional outcome after total and subtotal glossectomy with free flap reconstruction. Head Neck 30:909–918PubMedCrossRef

17.

Biller HF, Lawson W, Baek SM (1983) Total glossectomy. A technique of reconstruction eliminating laryngectomy. Arch Otolaryngol 109:69–73PubMedCrossRef

18.

Fujimoto Y, Hasegawa Y, Yamada H et al (2007) Swallowing function following extensive resection of oral or oropharyngeal cancer with laryngeal suspension and cricopharyngeal myotomy. Laryngoscope 117:1343–1348PubMedCrossRef

19.

McColl HA Jr, Horwood J (1978) ‘Localized’ carcinoma of the mobile tongue and floor of mouth—a lesion frequently misjudged and undertreated. J Surg Oncol 10:337–345PubMedCrossRef

20.

Hicks WL Jr, Lorre TR, Garcia RI et al (1997) Squamous cell carcinoma of the floor of mouth: a 20-year review. Head Neck 19:400–405PubMedCrossRef

21.

Boyd JB, Mulholland RS, Davidson J et al (1995) The free flap and plate in oromandibular reconstruction: long-term review and indications. Plast Reconstr Surg 95:1018–1028PubMed

22.

Head C, Alam D, Sercarz JA et al (2003) Microvascular flap reconstruction of the mandible: a comparison of bone grafts and bridging plates for restoration of mandibular continuity. Otolaryngol Head Neck Surg 129:48–54PubMedCrossRef

23.

Takushima A, Harii K, Asato H et al (2001) Mandibular reconstruction using microvascular free flap: a statistical analysis of 178 cases. Plast Reconstr Surg 108:1555–1563PubMed

24.

Hao SP, Cheng MH (2004) Cancer of the buccal mucosa and retromolar trigone. Oper Tech Otolaryngol 15:239–251CrossRef

25.

Ozkan O, Mardini S, Chen HC et al (2006) Repair of buccal defects with anterolateral thigh flaps. Microsurgery 26:182–189PubMedCrossRef

26.

Liu WW, Yang AK, Ou YD (2011) The harvesting and insetting of a chimeric anterolateral thigh flap to reconstruct through and through cheek defects. Int J Oral Maxillofac Surg 40:1421–1423PubMedCrossRef

27.

Mendenhall WM, Morris CG, Amdur RJ et al (2005) Retromolar trigone squamous cell carcinoma treated with radiotherapy alone or combined with surgery. Cancer 103:2320–2325PubMedCrossRef

28.

Genden FM, Ferito A, Shaha AR et al (2003) Management of cancer of the retromolar trigone. Oral Oncol 39:633–637PubMedCrossRef

29.

McGregor AD, MacDonald DG (1988) Routes of entry of squamous cell carcinoma to the mandible. Head Neck 10:294–301CrossRef

30.

Totsuka Y, Usui Y, Tei K et al (1991) Mandibular involvement by squamous cell carcinoma of the lower alveolus. Analysis and comparative study of histologic and radiologic features. Head Neck 13:40–50PubMedCrossRef

31.

Virag MM, Bunarević A, Aljinović N (1991) Recurrences of oral cancer due to discontinuous periosteal involvement. Am J Surg 162:388–392PubMedCrossRef

32.

Fujibayashi T (2004) Level of mandibular canal (LMC) criteria of lower gingival carcinomas and mode of mandibulectomy according to LMC criteria and bone invasion pattern. J Jpn Soc Oral Tumors 16:35–48CrossRef

33.

Totsuka Y, Usui Y, Tei K et al (1991) Results of surgical treatment for squamous carcinoma of the lower alveolus: segmental vs marginal resection. Head Neck 13:114–120PubMedCrossRef

34.

Ord RA, Sarmadi M, Papadimitrou J (1997) A comparison of segmental and marginal bony resection for oral squamous cell carcinoma involving the mandible. J Oral Maxillofac Surg 55:470–477PubMedCrossRef

35.

Politi M, Costa F, Robiony M et al (2000) Review of segmental and marginal resection of the mandible in patients with oral cancer. Acta Otolaryngol 120:569–579PubMedCrossRef

36.

Wax MK, Bascom DA, Myers LL (2002) Marginal mandibulectomy vs segmental mandibulectomy, indication and controversies. Arch Otolaryngol Head Neck Surg 128:600–603PubMedCrossRef

37.

Genden EM, Rinaldo A, Jacobson A et al (2005) Management of mandibular invasion: when is a marginal mandibulectomy appropriate? Oral Oncol 41:776–782PubMedCrossRef

38.

O’Brien CJ, Adams JR, McNeil EB et al (2003) Influence of bone invasion and extent of mandibular resection on local control of cancers of the oral cavity and oropharynx. Int J Oral Maxillofac Surg 32:492–497PubMedCrossRef

39.

Patel RS, Dirven R, Clark JR et al (2008) The prognostic impact of extent of bone invasion and extent of bone resection in oral carcinoma. Laryngoscope 118:780–785PubMedCrossRef

40.

Swearingen AG, McGraw JP, Palumbo VD (1966) Roentgenographic pathologic correlation of carcinoma of the gingival involving the mandible. Am J Roentogenol 96:15–18CrossRef

41.

Wong RJ, Keel SB, Glynn RJ et al (2000) Histological pattern of mandibular invasion by oral squamous cell carcinoma. Laryngoscope 110:65–72PubMedCrossRef

42.

Nomura T, Shibahara T, Cui NH et al (2005) Patterns of mandibular invasion by gingival squamous cell carcinoma. J Oral Maxillofac Surg 63:1489–1493PubMedCrossRef

43.

Tei K, Totsuka Y, Iizuka T et al (2004) Marginal resection for carcinoma of the mandibular alveolus and gingiva where radiologically detected bone defects do not extend beyond the mandibular canal. J Oral Maxillofac Surg 62:834–839PubMedCrossRef

44.

Werning JW, Byers RM, Novas MA et al (2001) Preoperative assessment for and outcomes of mandibular conservation surgery. Head Neck 23:1024–1030PubMedCrossRef

45.

Robbins KT, Clayman G, Levine PA et al (2002) Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology–Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 128:751–758PubMedCrossRef

46.

Sheahan P, O’Keane C, Sheahan JN et al (2003) Predictors of survival in early oral cancer. Otolaryngol Head Neck Surg 129:571–576PubMedCrossRef

47.

Veness MJ, Morgan GJ, Sathiyaseelan Y et al (2005) Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients? ANZ J Surg 75:101–105PubMedCrossRef

48.

Mark Taylor S, Drover C, Maceachern R et al (2010) Is preoperative ultrasonography accurate in measuring tumor thickness and predicting the incidence of cervical metastasis in oral cancer? Oral Oncol 46:38–41PubMedCrossRef

49.

Kurokawa H, Yamashita Y, Takeda S et al (2002) Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue. Head Neck 24:731–736PubMedCrossRef

50.

Sparano A, Weinstein G, Chalian A et al (2004) Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg 131:472–476PubMedCrossRef

51.

Lim SC, Zhang S, Ishii G et al (2004) Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res 10:166–172PubMedCrossRef

52.

Chien CY, Su CY, Hwang CF et al (2006) High expressions of CD105 and VEGF in early oral cancer predict potential cervical metastasis. J Surg Oncol 94:413–417PubMedCrossRef

53.

Capote A, Escorial V, Muñoz-Guerra MF et al (2007) Elective neck dissection in early-stage oral squamous cell carcinoma. Does it influence recurrence and survival ? Head Neck 29:3–11PubMedCrossRef

54.

Dias FL, Kligerman J, Matos de Sá G et al (2001) Elective neck dissection versus observation in stage I squamous cell carcinomas of the tongue and floor of the mouth. Otolaryngol Head Neck Surg 125:23–29PubMedCrossRef

55.

Keski-Santti H, Atula T, Törnwall J et al (2006) Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue. Oral Oncol 42:96–101PubMedCrossRef

56.

Asakage T, Kishimoto S, Saikawa M et al (2005) The standardization of neck dissection for tongue carcinoma. Jpn Head Neck Cancer 31:536–540

57.

Weiss M, Harrison LB, Isaacs RS (1994) Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 120:699–702PubMedCrossRef

58.

Majoufre C, Faucher A, Laroche C et al (1999) Supraomohyoid neck dissection in cancer of the oral cavity. Am J Surg 178:73–77PubMedCrossRef

59.

Yu S, Li J, Zhang W et al (2006) Efficacy of supraomohyoid neck dissection in patients with oral squamous cell carcinoma and negative neck. Am J Surg 191:94–99PubMedCrossRef

60.

Byers RM, Weber RS, Andrews T et al (1997) Frequency and therapeutic implications of “skip metastases” in the neck from squamous carcinoma of the oral tongue. Head Neck 19:14–19PubMedCrossRef

61.

Dias FL, Lima RA, Kligerman J et al (2006) Relevance of skip metastases for squamous cell carcinoma of the oral tongue and the floor of the mouth. Otolaryngol Head Neck Surg 134:460–465PubMedCrossRef

62.

Ferlito A, Silver CE, Rinaldo A (2009) Elective management of the neck in oral cavity squamous carcinoma: current concepts supported by prospective studies. Br J Oral Maxillofac Surg 47:5–9PubMedCrossRef

63.

Terada A, Hasegawa Y, Yatabe Y et al (2011) Follow-up after intraoperative sentinel node biopsy of N0 neck oral cancer patients. Eur Arch Otorhinolaryngol 268:429–435PubMedCrossRef

64.

Melkane AE, Mamelle G, Wycisk G et al (2012) Sentinel node biopsy in early oral squamous cell carcinomas: a 10-year experience. Laryngoscope 122:1782–1788PubMedCrossRef

65.

Broglie MA, Haerle SK, Huber GF et al (2013) Occult metastases detected by sentinel node biopsy in patients with early oral and oropharyngeal squamous cell carcinomas: impact on survival. Head Neck 35:660–666PubMedCrossRef

66.

O’Brien CJ, Urist MM, Maddox WA (1987) Modified radical neck dissection. Terminology, technique, and indications. Am J Surg 153:310–316PubMedCrossRef

67.

Kowalski LP, Bagietto R, Lara JR et al (2000) Prognostic significance of the distribution of neck node metastasis from oral carcinoma. Head Neck 22:207–214PubMedCrossRef

68.

Shingaki S, Nomura T, Takada M et al (1999) The impact of extranodal spread of lymph node metastases in patients with oral cancer. Int J Oral Maxillofac Surg 28:279–284PubMedCrossRef

69.

Cooper JS, Pajak TF, Forastiere AA et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944PubMedCrossRef

70.

Bernier J, Domenge C, Ozsahin M et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952PubMedCrossRef

71.

Ozeki S, Tashiro H, Okamoto M et al (1985) Metastasis to the lingual lymph node in carcinoma of the tongue. J Maxillofac Surg 13:277–281PubMedCrossRef

72.

Ando M, Asai M, Asakage T et al (2009) Metastatic neck diseases beyond the limits of a neck dissection: attention to the ‘para-hyoid’ area in T1/2 oral tongue cancer. Jpn J Clin Oncol 39:231–236PubMedCrossRef

73.

Tseng JR, Ho TY, Lin CY et al (2013) Clinical outcomes of patients with oral cavity squamous cell carcinoma and retropharyngeal lymph node metastasis identified by FDG PET/CT. PLoS One 8(11):e79766PubMedCentralPubMedCrossRef

74.

Gross ND, Ellingson TW, Wax MK et al (2004) Impact of retropharyngeal lymph node metastasis in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130:169–173PubMedCrossRef

75.

Umeda M, Shigeta T, Takahashi H et al (2009) Metastasis to the lateral retropharyngeal lymph node from squamous cell carcinoma of the oral cavity: report of three cases. Int J Oral Maxillofac Surg 38:1004–1008PubMedCrossRef

76.

Hasegawa Y, Matsuura H (1994) Retropharyngeal node dissection in cancer of the oropharynx and hypopharynx. Head Neck 16:173–180PubMedCrossRef

77.

Omura K, Shimada F, Takemiya S (1985) Dissection of parapharyngeal space in head and neck cancer. Auris Nasus Larynx 12(Suppl 2):S56–S60PubMed

78.

Huang J, Barbera L, Brouwers M et al (2003) Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 21:555–563PubMedCrossRef

79.

Robbins KT, Kumar P, Regine WF et al (1997) Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys 38:263–271PubMedCrossRef

80.

Furusaka T, Asakawa T, Tanaka A et al (2012) Efficacy of multidrug superselective intra-arterial chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) using the Seldinger technique for tongue cancer. Acta Otolaryngol 132:1108–1114PubMedCrossRef

81.

Tohnai I, Fuwa N, Hayashi Y et al (1998) New superselective intra-arterial infusion via superficial temporal artery for cancer of the tongue and tumour tissue platinum concentration after carboplatin (CBDCA) infusion. Oral Oncol 34:387–390PubMedCrossRef

82.

Mitsudo K, Shigetomi T, Fujimoto Y et al (2011) Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer. Int J Radiat Oncol Biol Phys 79:1428–1435PubMedCrossRef

83.

Chen IH, Chang JT, Liao CT et al (2003) Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis. Br J Cancer 89:681–686PubMedCentralPubMedCrossRef

84.

Bonner JA, Harari PM, Giralt J et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567–578PubMedCrossRef

Title: Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma
Author: Ken Omura
Publication date: 01-06-2014
Publisher: Springer Japan
Published in: International Journal of Clinical Oncology / Issue 3/2014
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-014-0689-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

Development of a novel interferon-α2b gene construct with a repetitive hypoxia-inducible factor binding site and its suppressive effects on human renal cell carcinoma cell lines in vitro

Predictive factors that influence the course of medullary thyroid carcinoma

Orally administered S-1 suppresses circulating endothelial cell counts in metastatic breast cancer patients

Improvement of prognosis in patients with metastatic renal cell carcinoma and Memorial Sloan-Kettering Cancer Center intermediate risk features by modern strategy including molecular-targeted therapy in clinical practice

Possible peripheral mechanism for taste disorder in rats administered S-1

Update of molecular pathobiology in oral cancer: a review

Keynote webinar | Spotlight on antibody–drug conjugates in cancer